TransMedics Group Inc (NASDAQ:TMDX) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 ...
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
New York, New York-- (Newsfile Corp. - February 25, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX ...
Global Retirement Partners LLC increased its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...
Allspring Global Investments Holdings LLC trimmed its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates ...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, ...
1d
Zacks.com on MSNCurious about TransMedics (TMDX) Q4 Performance? Explore Wall Street Estimates for Key MetricsBeyond analysts' top -and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results